Skip to content

BUMA PHARMA

Active
Private limited companyfounded 20233 years activeOudestraat 121, 2610 Antwerpen, BelgiumKBO/BCE: BE 0803.488.513
Summary

BUMA PHARMA has been active since 2023 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €38,507 and a net result of €14,746. Equity is growing by ~57.8% per year across the filed fiscal years. Its solvency ranks better than 78% of 22,078 sector peers (NACE 47, fiscal year 2025). The computed 12-month bankruptcy probability is 0.3% (very low).

Risk analysisWatch ReportCompare
BUMA PHARMAActiveChecked score 91/100
Risk analysis ReportCompare

History

On 3 July 2023, BUMA PHARMA was incorporated as a Private limited company.1 Total assets went from €24,410 in 2023 to €57,247 in 2025.2

  1. 1Crossroads Bank for Enterprises
  2. 2National Bank, annual accounts 2023 and 2025

Acts, filings and financial milestones

Next filing, fiscal year 2026, expected by 31-07-2027
2026
05-08
NBB filing Annual accounts filed
fiscal year 2025 · micro schema · 5 days late
2025
30-08
NBB filing Annual accounts filed
fiscal year 2024 · micro schema · 30 days late
2024
31-12
Financial Highest result since 2023net €15,368 ▲54.9%
Operating result €21,677, net result €15,368, both a record.
30-08
NBB filing Annual accounts filed
fiscal year 2023 · micro schema · 30 days late
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
0 of 1 act read
About the unread acts

We know of 1 Belgian State Gazette act for this company. It has not been read yet: what they contain is neither established nor disproved here.

Have them read with priority Sign in to place this company at the front of the reading queue.

We would like to set cookies. That happens only with your consent. What we measure